Skip to main content
U.S. flag

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock (  ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Find more clinical trials

Risk Evaluation and Education for Alzheimer's Disease (REVEAL) IV

Start: January 2010
End: July 2014
Enrollment: 360

What Is This Study About?

This study will examine the impact of receiving a genetic risk assessment for Alzheimer's disease among individuals with mild cognitive impairment (MCI).

Do I Qualify To Participate in This Study?

Minimum Age: 55 Years

Maximum Age: 90 Years

Must have:

++Amnestic mild cognitive impairment (as defined by the Petersen criteria)++Fluent in English++Close friend, relative, or spouse willing to attend each study visit with the participant and complete surveys and interviews

Must NOT have:

++Current untreated anxiety or depression++Diagnosis of dementia or Alzheimer's disease

If I Qualify, Who Do I Contact?

Contact study personnel listed either under the general study contact or the location nearest you.

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

Who Sponsors This Study?

Lead: Brigham and Women's Hospital

Collaborator Sponsor

  • National Human Genome Research Institute (NHGRI)
  • University of Michigan
  • University of Pennsylvania
  • Howard University

Source: ClinicalTrials.gov ID: NCT01434667

alzheimers.gov

An official website of the U.S. government, managed by the National Institute on Aging at the National Institutes of Health